Location History:
- Shihezi, CN (2023)
- Xinjiang, CN (2024)
Company Filing History:
Years Active: 2023-2024
Title: The Innovative Contributions of Peng Wu
Introduction
Peng Wu is a prominent inventor based in Shihezi, China. He has made significant contributions to the field of biomedical technology, particularly in the development of nanobodies. With a total of 3 patents to his name, his work focuses on innovative solutions for medical applications.
Latest Patents
Among his latest patents is the TIM-3 nanobody, which includes a preparation method and its applications. This invention pertains to the technical field of animal or human antibodies. The TIM-3 nanobody is characterized by the sequence of SEQ ID NO:1. The TIM-3 antigen is transiently transfected and expressed by mammalian cells. This method ensures that the original structure and activity of the protein are maximized, allowing for efficient and specific binding to the target.
Another notable patent involves a nano-antibody based on the SARS-CoV-2 S protein. This invention relates to biomedical technology and utilizes the Spike S1+S2 ECD of SARS-CoV-2 as a target. The nanobody library is screened against SARS-CoV-2, and after conducting an ELISA test, the nanobody demonstrates a strong binding signal to the target. The purification process yields a nanobody with a purity greater than 90%, showcasing its high affinity to the targets.
Career Highlights
Peng Wu is affiliated with Shihezi University, where he continues to advance his research in the field of nanobodies and their applications. His work has garnered attention for its potential impact on medical treatments and diagnostics.
Collaborations
He collaborates with notable colleagues, including Chuangfu Chen and Chencheng Xiao, who contribute to his research endeavors.
Conclusion
Peng Wu's innovative work in the field of nanobodies exemplifies the potential of biomedical technology to address pressing health challenges. His contributions are paving the way for future advancements in medical science.